Impact Factor
3.85
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.79
2,095 total citations
h5-index
45
h5 depth signal
Cited share
78.2%
453 of 579
Total citations
2,095
Citation footprint
Metric signal
3.55
External metric anchor
Self-citation
1.5%
32 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
980
India
932
United States
533
Italy
413
Iran
340
Citing Fields of Research
Drug Delivery Systems
731
Phytochemicals
568
Cardiology
464
Immunology
325
Neurodegenerative Disorders
284
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
11,520
Articles tracked across the journal lifetime
Indexed publication set
579
453 cited publications
Last 12 months
535
44.6 publications/month
Open access share
2.8%
15 OA publications in the last year
Leading citing country
China
980 citing publications
Leading citing field
Drug Delivery Systems
731 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Feb. 1998-
v4n1, Feb. 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Phytochemicals
Nanoparticles
Immunology
Neurodegenerative Disorders
Diabetes
Broad Categories
Pharmacology
Drug Delivery Systems
Phytochemicals
Polymer & Macromolecule Science
Noncoding RNA
Urology
Nanoparticles
Molecular & Cellular Toxicology
MeSH Descriptors
Drug Design
Technology, Pharmaceutical
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/0113816128447768260915075822
Open DOI
Design, In Silico Targeting, and Characterization of Curcumin-Ibuprofen Prodrug Microspheres for Brain-Specific Delivery in Alzheimer’s Therapy
Introduction: Alzheimer’s Disease (AD) is a complex neurodegenerative condition characterized by limited treatment effectiveness, attributed to inadequate Blood-Brain Barrier (BBB) permeability and low medication absorption. Curcumin and...
02
DOI 10.2174/0113816128503772261007160416
Open DOI
Decoding Pyroptosis in Pulmonary Fibrosis: Molecular Mechanisms and Therapeutic Horizons
Background: Pulmonary fibrosis (PF) is a progressive and fatal interstitial lung disease characterized by the depletion of alveolar epithelial cells (AECs) and the pathological accumulation of extracellular matrix (ECM). Despite its high...
03
DOI 10.2174/0113816128499933261007092826
Open DOI
Diindolylmethane Pretreatment Attenuated Thioacetamide-Induced Acute Liver Failure and its Associated Brain Injury in Rats
Introduction: Acute liver failure (ALF) is a life-threatening condition associated with hepatic encephalopathy (HE), characterised by neurological impairments, hyperammonemia, oxidative stress, and inflammation. Diindolylmethane (DIM), a...
04
DOI 10.2174/0113816128537581261007065942
Open DOI
Emerging Therapeutic Strategies for Graves’ Disease: Current Advances and Future Perspectives
Graves’ Disease (GD) is the leading cause of autoimmune hyperthyroidism and is still considered a challenging clinical condition. Antithyroid drugs, radioactive iodine, and thyroidectomy have long been used as main treatments. These appr...
05
DOI 10.2174/0113816128503157261002161713
Open DOI
Therapeutic Potential of Flavonoids and Their Metabolites in Hyperlipidaemia: Molecular Mechanisms, Bioavailability and Clinical Perspectives
Hyperlipidaemia is a major modifiable risk factor for cardiovascular disease and remains a global health concern. Although conventional lipid-lowering drugs are effective, their long-term use is often associated with adverse effects, pro...
06
DOI 10.2174/0113816128513962260928173852
Open DOI
Rational Use of Analgesic Agents in Elderly Patients: Implications of the Beers Criteria and STOPP/START Algorithms
Introduction/Objective: Pain affects approximately 30% of community-dwelling older adults and more than half of nursing-home residents but remains undertreated because age-related pharmacokinetic and pharmacodynamic changes render standa...
07
DOI 10.2174/0113816128504944260930051855
Open DOI
UPLC-Q-TOF/MS, Network Pharmacology, and Experimental Validation Reveal the Mechanisms of Shuangbai Tablet Against Albuminuria
Introduction: Shuangbai Tablet (SBT), a traditional Chinese medicine, has demonstrated efficacy in reducing albuminuria. This study aimed to investigate the therapeutic mechanisms underlying its antialbuminuric effects. Methods: The phyt...
08
DOI 10.2174/0113816128493042260929104240
Open DOI
Medicinal Plants in the Management of Anxiety Disorders: Clinical Evidence, Mechanisms, and Safety Considerations
Anxiety disorders are among the most prevalent neuropsychiatric conditions worldwide and represent a major public health burden. Although conventional pharmacological treatments are effective, their long-term use is often limited by adve...
09
DOI 10.2174/0113816128485741260930182421
Open DOI
Dietary Acrylamide-Glycidamide Exposure and Metabolic Toxicity: Emerging Evidence in Type 2 Diabetes
Introduction: Acrylamide is present in a variety of cooked and processed foods, but its precise role in the biological mechanisms underlying type 2 diabetes (T2D) remains incompletely understood. This review aimed to comprehensively eval...
10
DOI 10.2174/0113816128510427260927100857
Open DOI
Cannabinoids for Acute Pain Management: A Contemporary Scoping Review of Evidence, Mechanisms, and Clinical Implications
Background: The global opioid crisis has intensified interest in non-opioid and opioid-sparing analgesic strategies, including cannabinoids. Despite the expanding legal landscape for cannabis and a rapidly growing cannabinoid market, the...
Bibliographical & Catalog Notes
Title from cover.
Vol. 1 complete in 4 issues.
Also issued online.